Fundz

Attivare Therapeutics

Massachusetts, United States · Biotechnology, Health Care, Therapeutics · 7 employees

Attivare Therapeutics, Inc. is a pre-clinical stage biotechnology company pioneering new treatments for cancer and infectious diseases through its innovative immune-activating scaffold platform, ATTimmune.

Funding history

  • Funding Round — $6.6M — Dec 2025

Recent signals

  • Dec 15, 2025: Raised $6.6M

See plans & pricing → Track Attivare Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.